ImmunoVec, Inc. — Form D
ImmunoVec, Inc. of Los Angeles, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-01. The offering totals $4.3M, of which $4.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-03-01
- Form: D
- Accession: 0001914272-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.3M
- Amount sold: $4.3M
- Investors: 25
- Date of first sale: 2021-11-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-435440
Issuer
- Name: ImmunoVec, Inc.
- CIK: 0001914272
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3435 Wilshire Blvd Suite 2700-84, Los Angeles, CA, 90010
- Phone: 630-802-0139
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Dillon Woodward | Director | Santa Monica, CA |
| William Woodward | Director | Los Angeles, CA |
| William Woodward | Executive Officer | Los Angeles, CA |
| William Woodward | Promoter | Los Angeles, CA |
| William Woodward | Related Person | Los Angeles, CA |
| Chris Lucas | Related Person | Los Angeles, CA |
| Ryan Wong | Related Person | Los Angeles, CA |
| Douglass Lorenzen | Related Person | Los Angeles, CA |
Other filings by this issuer (1)
More